Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling tuberculosis in India

Zarir F Udwadia

    The New England Journal of Medicine
    |February 21, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Implications of Acetylator Status and Therapeutic Drug Monitoring of Plasma Rifampicin and Isoniazid Concentrations among Indians.

    The Journal of the Association of Physicians of India·2026
    Same author

    Development and validation of the Hypersensitivity Pneumonitis South Asian Questionnaire for Exposure (HP-SAQE): a novel, qualitative and quantitative tool.

    Thorax·2026
    Same author

    Quantitation of Plasma Bedaquiline Concentrations in Indian MDR-TB Patients Using Liquid Chromatography-Tandem Mass Spectrometry.

    Biomedical chromatography : BMC·2025
    Same author

    Evaluation of cycloserine dose regimens in an Indian cohort with multidrug-resistant tuberculosis: a population pharmacokinetic analysis.

    Antimicrobial agents and chemotherapy·2025
    Same author

    Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

    The European respiratory journal·2023
    Same author

    COVID-19 in the Asia Pacific: Impact on climate change, allergic diseases and One Health.

    Asia Pacific allergy·2023
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles